Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 1:06 AM
Ignite Modification Date:
2025-12-25 @ 1:06 AM
NCT ID:
NCT00484393
Eligibility Criteria:
Inclusion Criteria:
* Infants between 1 month and 2 years of age receiving palivizumab at Surrey Memorial Hospital for 2 consecutive intramuscular injections during the 2007/8 season
* Parents need to complete informed consent.
Exclusion Criteria:
* Allergy/sensitivity to tetracaine, or ester type anaesthetics.
* Infants who present with fever or illness that prevent administration of palivizumab.
Healthy Volunteers:
True
Sex:
ALL
Minimum Age:
1 Month
Maximum Age:
2 Years
Study:
NCT00484393
Study Brief:
Protocol Section:
NCT00484393